Crescent Biopharma, Inc. (CBIO)
11.65
-0.09
(-0.77%)
USD |
NASDAQ |
Feb 20, 16:00
11.67
+0.02
(+0.17%)
After-Hours: 20:00
Crescent Biopharma SG&A Expense (Quarterly) : 5.538M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| XOMA Royalty Corp. | 9.734M |
| Viridian Therapeutics, Inc. | 24.32M |
| DiaMedica Therapeutics, Inc. | 2.596M |
| Denali Therapeutics, Inc. | 35.48M |
| Praxis Precision Medicines, Inc. | 19.54M |